News Search Results

Viewing Page 2 of 54 | Showing Results 11 - 20 of 540

Renal cancer studies at Providence Cancer Institute

October 30, 2017

T-cell checkpoint antibodies have revolutionized immunotherapy for cancer, including renal cancer. At Providence Cancer Institute, several clinical trials of these novel approaches are now open to patients with renal cancer, including two studies comparing the effectiveness of different combinations of targeted therapies and immunotherapies.

Tomi Ryba is new chief executive for Providence in Southern Oregon

October 19, 2017

MEDFORD, Ore. - Tomi Ryba, a proven leader with extensive health care experience, has been named chief executive for Providence’s Southern...

Providence Honors Early Advocate of Immunotherapy for Lifetime of Generosity and Service

October 03, 2017

In his lifetime and through his estate, the late Robert W. Franz gave close to $40 million to Providence Portland Medical Foundation. Providence Cancer Institute has been renamed in his honor.

Phase I research at Providence Cancer Institute

September 25, 2017
Phase I studies are the foundation for advancing cancer treatment with new agents and combinations of therapies. Providence Cancer Institute is often able to offer patients first-in-human clinical trials of novel cancer therapies through our own investigator-sponsored trials, and through collaborations with industry sponsors and other early-phase institutions around the country and worldwide.

Providence Lifeline Medical Alert Service

September 05, 2017

Effective Sept. 1, 2017, services previously provided by Providence Lifeline are now provided by Tunstall Americas, a global leader in personal...

Providence School Outreach Newsletter

September 05, 2017

Learn more about our program and school outreach opportunities throughout the year from our quarterly newsletter.

Promising one-of-a-kind clinical trial adds immunotherapy to colorectal cancer treatment protocol

September 01, 2017

A first-of-its-kind clinical study may offer new hope to patients battling rectal cancer. The Phase 2 study, newly underway at Providence Cancer...

Providence Wellness Watch: Breast Cancer Screening

September 01, 2017

Learn more about breast cancer screening and the importance of mammograms, featuring Dr. Anupama Acheson from Providence Cancer Institute.

PATINA trial studies targeted therapy for breast cancer

August 28, 2017

Patients with hormone-receptor-positive, HER2-positive metastatic breast cancer may qualify for a newly opened clinical trial at Providence Cancer...

Health Watch News Segment Features Optimal Aging

August 03, 2017

Last month, Optimal Aging was featured in a news segment on Fox 12 Oregon. A current Optimal Aging client and his wife were interviewed along with Marika Rausa, Director, Consumer Strategy & Innovation, Optimal Aging.

Viewing Page 2 of 54 | Showing Results 11 - 20 of 540